Kornitzer Capital Management Inc. KS increased its stake in Natera, Inc. (NASDAQ:NTRA) by 22.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 436,290 shares of the medical research company’s stock after buying an additional 79,325 shares during the period. Kornitzer Capital Management Inc. KS owned about 0.83% of Natera worth $4,738,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in NTRA. GSA Capital Partners LLP bought a new position in Natera during the fourth quarter valued at approximately $121,000. Russell Investments Group Ltd. bought a new position in Natera during the fourth quarter valued at approximately $130,000. American International Group Inc. increased its position in Natera by 7.1% in the first quarter. American International Group Inc. now owns 16,065 shares of the medical research company’s stock valued at $142,000 after buying an additional 1,068 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in Natera by 1.2% in the first quarter. Massachusetts Financial Services Co. MA now owns 16,118 shares of the medical research company’s stock valued at $143,000 after buying an additional 194 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its position in Natera by 45.3% in the first quarter. Goldman Sachs Group Inc. now owns 17,386 shares of the medical research company’s stock valued at $154,000 after buying an additional 5,417 shares in the last quarter. Hedge funds and other institutional investors own 59.51% of the company’s stock.

Natera, Inc. (NASDAQ:NTRA) opened at 8.29 on Friday. Natera, Inc. has a 12-month low of $7.35 and a 12-month high of $13.39. The stock’s market cap is $438.39 million. The stock has a 50 day moving average price of $10.36 and a 200 day moving average price of $9.58.

Natera (NASDAQ:NTRA) last announced its earnings results on Tuesday, May 9th. The medical research company reported ($0.70) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.61) by $0.09. The business had revenue of $46.90 million for the quarter, compared to analysts’ expectations of $42.82 million. Natera had a negative net margin of 60.89% and a negative return on equity of 101.63%. The firm’s quarterly revenue was down 24.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.17) earnings per share. On average, analysts forecast that Natera, Inc. will post ($2.01) earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Kornitzer Capital Management Inc. KS Has $4.74 Million Stake in Natera, Inc. (NTRA)” was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.dailypolitical.com/2017/08/06/kornitzer-capital-management-inc-ks-has-4-74-million-stake-in-natera-inc-ntra.html.

Several research firms have recently commented on NTRA. BidaskClub downgraded Natera from a “buy” rating to a “hold” rating in a report on Tuesday, July 25th. ValuEngine downgraded Natera from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. Canaccord Genuity lifted their price objective on Natera from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Wednesday, May 10th. Finally, Zacks Investment Research downgraded Natera from a “buy” rating to a “hold” rating in a report on Thursday, May 11th. Four investment analysts have rated the stock with a sell rating and three have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $15.25.

Natera Company Profile

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.